In-Vitro Testing of Pregnancy Malaria Vaccine Candidates

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: \- Malaria is a disease that affects many people in African countries. It is caused by germs that are spread by mosquito bites. It can be fatal if not diagnosed and treated right away. Children younger than 5 and pregnant women are most at risk to get malaria. Researchers want to create a vaccine that will prevent malaria infection during pregnancy.

Objectives: \- To create a vaccine that will prevent malaria infection during pregnancy. To assess possible vaccines using in-vitro tests with parasites taken from pregnant women.

Eligibility: \- Pregnant women ages 15-25

Design: * The study site is an area in Mali, West Africa. * Participants: * Will have blood drawn. * Will give consent for the blood sample to be used for future research. * May have a physical exam. * Participants who have malaria or anemia will get treatment.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 15
Maximum Age: 25
Healthy Volunteers: t
View:

⁃ A study participant must satisfy the following criteria to be enrolled in this study:

• Pregnant women aged 15-25 years

• Able to provide consent for self

• Malaria positive by rapid diagnostic test (RDT)

Locations
Other Locations
Mali
Ouelessebougou Clinical Research Center
RECRUITING
Bamako
Contact Information
Primary
Michal Fried, Ph.D.
michal.fried@nih.gov
(240) 747-7880
Time Frame
Start Date: 2015-07-28
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 7476
Treatments
Pregnant Women 15-25 years old
Malaria-infected pregnant Women
Related Therapeutic Areas
Sponsors
Leads: National Institute of Allergy and Infectious Diseases (NIAID)

This content was sourced from clinicaltrials.gov